TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · major macro event coming up
AVLN

Avalyn Pharma Inc.

Healthcare · Biotechnology

27.10$ -4.3% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AVLN
Line item 2024 2025
100.0% 100.0%
91.9% 96.4%
19.2% 35.1%
– 92.9%
– 0.4%
240.2% 260.3%
7.0% 9.5%
– 0.3%
1.8% 2.5%
-140.2% -160.3%
-144.7% -178.2%
33.6% 28.1%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?